These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 10819579)

  • 81. Intratumoral expression of MIP-1beta induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells.
    Luo X; Yu Y; Liang A; Xie Y; Liu S; Guo J; Wang W; Qi R; An H; Zhang M; Xu H; Guo Z; Cao X
    Cell Mol Immunol; 2004 Jun; 1(3):199-204. PubMed ID: 16219168
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Vaccination with tumor cells engineered to secrete interleukin 2-immunoglobulin G fusion protein induces tumor rejection.
    Bulfone-Paus S; von Bernuth H; Rückert R; Wachtlin J; Ungureanu D; Notter M; Krause H; Pohl T; Paus R; Kunzendorf U
    Cancer Res; 1998 Jul; 58(13):2707-10. PubMed ID: 9661877
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Role of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762.
    Frey AB
    J Immunol; 1996 May; 156(10):3841-9. PubMed ID: 8621922
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
    Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
    Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Vaccination with IL-2-secreting tumor cells stimulates the generation of IL-2-responsive T cells and prevents the development of unresponsiveness.
    Zier KS; Salvadori S; Cronin KC; Gansbacher B
    Cancer Gene Ther; 1994 Mar; 1(1):43-50. PubMed ID: 7621237
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumour cells: mechanisms of tumour rejection and immunotherapeutical implications.
    Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Huleihel M; Fima E; Hacham M; Voronov E
    Folia Biol (Praha); 1994; 40(1-2):1-18. PubMed ID: 7958060
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Insertion of the IL-2 gene decreases tumorigenicity of murine fibrosarcoma.
    Kuśnierczyk H; Załecki P; Pajtasz-Piasecka E; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1998; 46(4):259-65. PubMed ID: 9779293
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Augmentation of vaccination effects of PGE2-producing tumor cells by transfection with cytokine genes].
    Ohiro Y
    Hokkaido Igaku Zasshi; 1997 May; 72(3):273-84. PubMed ID: 9226467
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Lymphokine-activated tumor inhibition in vivo. I. The local administration of interleukin 2 triggers nonreactive lymphocytes from tumor-bearing mice to inhibit tumor growth.
    Forni G; Giovarelli M; Santoni A
    J Immunol; 1985 Feb; 134(2):1305-11. PubMed ID: 3871210
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo.
    Hazama S; Noma T; Wang F; Iizuka N; Ogura Y; Yoshimura K; Inoguchi E; Hakozaki M; Hirose K; Suzuki T; Oka M
    Br J Cancer; 1999 Jul; 80(9):1420-6. PubMed ID: 10424745
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Enhanced inhibition of tumour growth and metastasis, and induction of antitumour immunity by IL-2-IgG2b fusion protein.
    Budagian V; Nanni P; Lollini PL; Musiani P; Di Carlo E; Bulanova E; Paus R; Bulfone-Paus S
    Scand J Immunol; 2002 May; 55(5):484-92. PubMed ID: 11975760
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor.
    Fioretti F; Fradelizi D; Stoppacciaro A; Ramponi S; Ruco L; Minty A; Sozzani S; Garlanda C; Vecchi A; Mantovani A
    J Immunol; 1998 Jul; 161(1):342-6. PubMed ID: 9647242
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells.
    Vagliani M; Rodolfo M; Cavallo F; Parenza M; Melani C; Parmiani G; Forni G; Colombo MP
    Cancer Res; 1996 Feb; 56(3):467-70. PubMed ID: 8564954
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Rescue of the tumor-specific immune response of aged mice in vitro.
    Urban JL; Schreiber H
    J Immunol; 1984 Jul; 133(1):527-34. PubMed ID: 6609995
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Induction of tumor immunity by cytokine cDNA transfected Lewis lung carcinoma].
    Ohira T; Ohe Y; Saijo N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():48-51. PubMed ID: 1306238
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Enhanced immune functions and antitumor activity of fibroblast-mediated interleukin-2 gene therapy].
    Cao XT; Zhang WP; Tao Q
    Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):521-4, 573. PubMed ID: 8556540
    [TBL] [Abstract][Full Text] [Related]  

  • 97. CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy.
    Frangione V; Mortara L; Castellani P; De Lerma Barbaro A; Accolla RS
    Int J Cancer; 2010 Oct; 127(7):1614-24. PubMed ID: 20091859
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Eosinophils infiltrating interleukin-5 gene-transfected tumors do not suppress tumor growth.
    Krüger-Krasagakes S; Li W; Richter G; Diamantstein T; Blankenstein T
    Eur J Immunol; 1993 Apr; 23(4):992-5. PubMed ID: 8458388
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Amount of interleukin 12 available at the tumor site is critical for tumor regression.
    Colombo MP; Vagliani M; Spreafico F; Parenza M; Chiodoni C; Melani C; Stoppacciaro A
    Cancer Res; 1996 Jun; 56(11):2531-4. PubMed ID: 8653692
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory.
    Klarnet JP; Matis LA; Kern DE; Mizuno MT; Peace DJ; Thompson JA; Greenberg PD; Cheever MA
    J Immunol; 1987 Jun; 138(11):4012-7. PubMed ID: 3108381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.